Thursday 23 March 2017

MAT SSRI X CHD

Genetic variants in maternal and fetal metabolic pathways for folate, homocysteine, and transsulfuration raised risk for congenital cardiac defects associated with selective serotonin reuptake inhibitors

No comments: